A phase I, first-in-human clinical trial of the GDF-15 neutralizing antibody CTL-002 in subjects with advanced-stage solid tumors (ACRONYM: GDFATHER)
Melero, I., Calvo, E., Dummer, R., Garralda, E., Schuler, M. H., Goebeler, M. E., . . .Tabernero, J., … Leo, … Read More
